Table 2 The league table for results based on event frequency estimates various agents according to their relative effects with odds ratio (95% confidence interval)

0.59 (0.35–0.97)

Bezafibrate (0.234)

0.94 (0.69–1.26)

0.55 (0.37–0.82)

0.94 (0.69–1.26)

Control (0.120)

1.32 (1.19–1.46)

1.56 (0.95–2.56)

3.21 (0.13–82.07)

1.07 (0.86–1.34)

1.53 (1.20–1.95)

1.04 (0.76–1.41)

2.00 (1.23–3.25)

1.08 (0.94–1.24)

1.32 (1.15–1.52)

2.38 (1.55–3.66)

0.72 (0.48–1.10)

1.23 (0.90–1.69)

1.32 (1.19–1.46)

EPA (0.505)

0.86 (0.45–1.62)

1.46 (0.82–2.61)

1.56 (0.95–2.56)

1.19 (0.72–1.96)

Ezetimibe (0.635)

1.76 (0.07–46.16)

3.01 (0.12–77.90)

3.21 (0.13–82.07)

2.43 (0.10–62.34)

2.05 (0.08–54.52)

Omega-3 fatty acid (0.693)

0.59 (0.37–0.93)

1.00 (0.69–1.45)

1.07 (0.86–1.34)

0.81 (0.63–1.04)

0.68 (0.40–1.18)

0.33 (0.01–8.58)

Fenofibrate (0.228)

0.84 (0.52–1.35)

1.43 (0.98–2.10)

1.53 (1.20–1.95)

1.16 (0.89–1.51)

0.98 (0.56–1.70)

0.48 (0.02–12.29)

1.43 (1.03–1.99)

Gemfibrozil (0.656)

0.57 (0.34–0.94)

0.97 (0.63–1.49)

1.04 (0.76–1.41)

0.78 (0.57–1.09)

0.66 (0.37–1.19)

0.32 (0.01–8.36)

0.97 (0.66–1.42)

0.68 (0.46–1.00)

Niacin (0.200)

1.10 (0.58–2.06)

1.87 (1.06–3.31)

2.00 (1.23–3.25)

1.52 (0.93–2.49)

1.28 (0.64–2.56)

0.62 (0.02–16.52)

1.87 (1.10–3.19)

1.31 (0.76–2.25)

1.93 (1.09–3.43)

Niacin Clofibrate (0.812)

0.59 (0.39–0.91)

1.01 (0.73–1.41)

1.08 (0.94–1.24)

0.82 (0.69–0.97)

0.69 (0.41–1.16)

0.34 (0.01–8.63)

1.01 (0.78–1.31)

0.71 (0.54–0.93)

1.04 (0.75–1.46)

0.54 (0.33–0.89)

Niacin Laropiprant (0.244)

0.73 (0.47–1.11)

1.24 (0.89–1.72)

1.32 (1.15–1.52)

1.00 (0.85–1.19)

0.85 (0.51–1.41)

0.41 (0.02–10.56)

1.24 (0.95–1.61)

0.86 (0.66–1.14)

1.28 (0.91–1.79)

0.66 (0.40–1.09)

1.22 (1.01–1.49)

Pravastatin (0.509)

1.31 (0.72–2.36)

2.23 (1.32–3.76)

2.38 (1.55–3.66)

1.81 (1.16–2.81)

1.53 (0.79–2.93)

0.74 (0.03–19.52)

2.23 (1.38–3.61)

1.56 (0.95–2.55)

2.30 (1.36–3.90)

1.19 (0.62–2.27)

2.20 (1.41–3.46)

1.80 (1.15–2.82)

Simvastatin (0.899)